By Stephen Lee
New York Post
Members of the wealthy Sackler family, owners of OxyContin maker Purdue Pharma, have long denied that the $10 billion they transferred from their company over the course of a decade was an unlawful attempt to shield assets in anticipation of litigation over their role in the opioid crisis.
But a review of e-mails, memos, depositions, legal motions and other documents unsealed late on Friday in Purdue’s bankruptcy proceedings…
Click the link below to read the rest of this story.